Home > Healthcare > Medical Devices > Diagnostic Devices > Blood Testing Market

Blood Testing Market Trends

Report ID: GMI2683
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Blood Testing Market Trends

The increasing technological breakthroughs for the development of innovative blood testing equipment will enhance the industry outlook. Lately, several firms are concentrating on the introduction of technologies that are non-invasive, cost-effective and highly accurate to provide patients with dependable findings. Numerous advances in ML and AI are also helping in tracking multiple variables while providing suitable therapy to patients. For instance, a recent upgrade to the DEXCOM G4 Platinum has an in-built hypoglycemic safety alarm as well as customizable notifications to monitor falls. Such advancements are anticipated to drive the market growth.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Blood testing industry size was worth USD 74.9 billion in 2022 and is set to grow at over 6.5% CAGR from 2023 to 2032 attributed to the growing burden of chronic and infectious diseases globally.

Blood testing market from the complete blood count test segment reached USD 11.1 billion in 2022 and is poised to record substantial growth through 2032 owing to the increasing prevalence of non-communicable diseases.

North America accounted for more than 32.6% revenue share of the blood testing market in 2022 and is estimated to reach USD 43.4 billion by 2032 attributed to favorable reimbursement policies, robust healthcare infrastructure, and supportive government initiatives.

Danaher (Beckman Coulter Inc. and Radiometer), F Hoffmann-La Roche Ltd., Abbott Laboratories, BioMerieux SA., Biomerica, Grifols, A.S, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc, Siemens Healthineers, Thermo Fisher Scientific Inc., and B. Braun Melsungen AG are some top companies